NOTE: This article reports on a new study that is not yet peer-reviewed.
A new pre-printed (non-peer-reviewed) study on vaccine efficacy suggests that vaccinations are effective against SARS-CoV-2 variants… until they aren’t. The study, published in Yale-owned medical journal medRxiv, was conducted by the following scientists:
Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helms, Hanne-Dorthe Emborg, Tyra Grove Krause, Kaare Moelbak, Palle Valentiner-Branth, The Infectious Disease Preparedness Group at Statens Serum Institute
The abstract of the study, below, says that vaccines are effective at protecting against the Omicron variant, but in the Delta variant, protection wanes “rapidly.” In just a matter of months, the jab is not effective at all, the studies find. Contrast that degree of defense against natural immunity, which can protect individuals from SARS-CoV-2 for years according to the latest information:
In this brief communication we are showing original research results with early estimates from Danish nationwide databases of vaccine effectiveness (VE) against the novel SARS-CoV-2 Omicron variant (B.1.1.529) up to five months after a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines. Our study provides evidence of protection against infection with the Omicron variant after completion of a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines; in particular, we found a VE against the Omicron variant of 55.2% (95% confidence interval (CI): 23.5 to 73.7%) and 36.7% (95% CI: -69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, in the first month after primary vaccination. However, the VE is significantly lower than that against Delta infection and declines rapidly over just a few months. The VE is re-established upon revaccination with the BNT162b2 vaccine (54.6%, 95% CI: 30.4 to 70.4%).
The abstract does not do a great job of explaining the most newsworthy findings, however. Deeper into the study, you can see that the scientists found that unvaccinated folks are actually 76.5% LESS likely to contract SARS-CoV-2 than those with a jab from the company.
Moderna vaccine effectiveness also provides relatively shoddy defense from the virus and its strains. Moderna customers are 39.3% more likely to contract the virus than unvaccinated people.
Rebel News chief Ezra Levant shared the study to Twitter with findings accompanying a screenshot, attached below:
“This study shows that after three months the vaccine effectiveness of Pfizer & Moderna against Omicron is actually negative. Pfizer customers are 76.5% more likely and Moderna customers are 39.3% more likely to be infected than unvaxxed people,” writes Levant:
We have known for some time that ‘health officials’ have been lying to us, and this study from Yale will surely be discredited by the media and the COVID-obsessed regime.
READ NEXT:
- Scientist Who Discovered Omicron Variant “Stunned” by Global Panic: “NOTHING Warrants This!” (DETAILS)
- MAXWELL TRIAL: Verdict ‘Highly Likely’ by Wednesday as Source Says Maxwell May Cooperate with DOJ. Here’s the Latest.
- Bill Gates BOUGHT the Media. Here’s How Much He Donates to Each ‘News’ Organization. (LIST)
23 Responses
great to see the review of these studies, we need more studies like this. We need more comparison studies also, for instance. How does Omicron COMPARE to the regular FLU in terms of Mortality?